本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Monopar Therapeutics

42.37
+0.0000
成交量:1,237.00
成交额:5.14万
市值:2.59亿
市盈率:-10.30
高:42.37
开:42.37
低:42.37
收:42.37
数据加载中...
2019/11/05

SEC问询函

[Cover]Correspondence
2019/11/04

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2019/11/04

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2019/10/02

SEC问询函

[Cover]Correspondence
2019/10/02

SEC问询函

[Cover]Correspondence
2019/10/01

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2019/09/30

SEC问询函

[Cover]Correspondence
2019/09/23

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/09/13

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2019/09/10

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2019/08/15

招股说明书

General form for registration of securities under the Securities Act of 1933
2019/08/08

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/06/27

重要事件披露

Current report, item 5.07
2019/05/10

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/02/26

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2018/12/11

SEC问询函

[Cover]Correspondence
2018/12/11

[修订]年度报告

[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]
2018/12/11

[修订]季度报告

[Amend] Quarterly report [Sections 13 or 15(d)]
2018/12/11

[修订]季度报告

[Amend] Quarterly report [Sections 13 or 15(d)]
2018/12/11

[修订]季度报告

[Amend] Quarterly report [Sections 13 or 15(d)]